Effect of dexamethasone on insulin binding, glucose transport, and glucose oxidation of isolated rat adipocytes

The Journal of Clinical Investigation
J M Olefsky

Abstract

We have studied the in vitro effects of dexamethasone on isolated rat adipocytes at concentrations of dexamethasone therapeutically achieved in man. Glucose oxidation, glucose transport, and insulin binding were assessed. In dexamethasone-treated cells, glucose oxidation was decreased by 30-40% both in the absence of insulin (basal state) and at low insulin levels (less than 25 mu/ML). At maximally effective insulin levels (over 100 muU/ml) no differences existed between control and treated cells. If glucose transport were the rate-limiting step for glucose oxidation in the basal state and at low (submaximal) insulin levels, but not at maximally effective insulin concentrations, then these data could be explained by postulating that dexamethasone has a direct affect on glucose transport and does not affect intracellular oxidative pathways. We tested this hypothesis by directly assessing glucose transport in dexamethasone-treated cells. Glucose transport was assessed by measuring the uptake of [14C]2-deoxy glucose. These studies demonstrated a 30-40% decrease in 2-deoxy glucose uptake by treated cells both in the basal state and at all insulin concentrations. Thus, a direct glucocorticoid effect on the glucose transport system s...Continue Reading

References

Jan 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·V BennettP Cuatrecasaş
Jun 1, 1975·Endocrinology·J M Olefsky, G M Reaven
Feb 3, 1975·Biochemical and Biophysical Research Communications·K K Tsuboi, J C Petricciani
Jan 1, 1974·Proceedings of the National Academy of Sciences of the United States of America·J R GavinD N Buell
Apr 1, 1974·The Journal of Clinical Endocrinology and Metabolism·J Olefsky, G M Reaven
Apr 29, 1974·Biochimica Et Biophysica Acta·M Hatanaka
Dec 16, 1974·Biochimica Et Biophysica Acta·P G Plagemann, D P Richey
Jun 14, 1972·Journal of Molecular Biology·G G RousseauG M Tomkins
Dec 11, 1974·Biochemical and Biophysical Research Communications·J N Livingston, D H Lockwood
Nov 24, 1972·Biochimica Et Biophysica Acta·J GliemannS Gammeltoft
Aug 17, 1973·Biochimica Et Biophysica Acta·S Gammeltoft, J Gliemann
Nov 1, 1972·The American Journal of Medicine·D FeldmanI S Edelman
Apr 16, 1971·Biochemical and Biophysical Research Communications·P FreychetD M Neville
Nov 1, 1967·The Journal of Endocrinology·R E Yorke

❮ Previous
Next ❯

Citations

Nov 1, 1988·Cytotechnology·N MoustaïdA Quignard-Boulangé
Sep 1, 1979·Diabetologia·B Jeanrenaud
Jul 1, 1989·Calcified Tissue International·E A ItuarteT J Hahn
Mar 11, 1999·Archives of Pharmacal Research·E S KimB J Lee
Oct 20, 1981·Biochimica Et Biophysica Acta·G J Leach, J A Spitzer
Sep 24, 1979·Life Sciences·E L TolmanR Partridge
Jun 1, 1984·Metabolism: Clinical and Experimental·S Röjdmark, K Lamminpää
Jan 1, 1986·Comparative Biochemistry and Physiology. A, Comparative Physiology·D H SmithF L Schanbacher
Dec 1, 1977·Molecular and Cellular Endocrinology·C CorrèzeA Gordon
Jan 1, 1990·Comparative Biochemistry and Physiology. C, Comparative Pharmacology and Toxicology·K A AkanbiC Y Hu
Sep 1, 1997·Physiology & Behavior·M ChavezS C Woods
Oct 1, 1992·Baillière's Clinical Endocrinology and Metabolism·J E Nestler, M A McClanahan
Oct 1, 1992·Baillière's Clinical Endocrinology and Metabolism·R E Ferner
Dec 20, 2000·Journal of Diabetes and Its Complications·S Dagogo-JackI Umamaheswaran
Jan 17, 1980·The New England Journal of Medicine·B D GivenR Poucher
Apr 30, 1981·The New England Journal of Medicine·O PedersenH Kromann
Jan 19, 2013·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Manfred HeckingUNKNOWN European-New-Onset Diabetes After Transplantation Working Group
Apr 1, 1992·Acta Physiologica Scandinavica·A Holmäng, P Björntorp
Jan 1, 1993·Mediators of Inflammation·J Garcia-Leme, S P Farsky
Jan 1, 1977·The Journal of Clinical Investigation·M B Davidson, S A Kaplan
Jul 1, 1978·The Journal of Clinical Investigation·M Kobayashi, J M Olefsky
Mar 1, 1979·The Journal of Clinical Investigation·J Segal, S H Ingbar
Jun 1, 1980·The Journal of Clinical Investigation·O G KoltermanJ M Olefsky
Jun 1, 1983·The Journal of Clinical Investigation·J W RoweJ S Flier
Jan 14, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Rachel L DerrStuart A Grossman
Apr 25, 2008·The Journal of Endocrinology·I J BujalskaP M Stewart
Oct 1, 1988·Journal of Neurosurgery·L H PerlingW R Cheek
Aug 1, 1978·Diabetologia·A Le Cam, P Freychet

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.